Following the outcome of the UK’s referendum on membership of the European Union, the UK BioIndustry Association (BIA) has worked closely with members and stakeholders to identify the threats and opportunities for biotech post-Brexit and to represent the sector. The BIA is leading bioscience industry engagement on Brexit with the UK government and also working collaboratively with them to deliver confidence in a time of uncertainty. Ultimately, the BIA's goal is to create a world-leading and globally competitive life sciences environment in the UK, outside of EU membership. Session attendees will learn about the development of UK policy post-Brexit and how it will affect UK and international companies alike.
Session ID: 22117